Methods to treat autoimmune and inflammatory conditions

Details for Australian Patent Application No. 2002241911 (hide)

International Classifications

Event Publications

13 February 2003 Application Open to Public Inspection

Published as AU-B-2002241911

30 October 2003 Section 223 Application Allowed

Newbiotics, Inc The time in which to enter the National Phase has been extended to 19 Sep 2003. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden ACT 2606

18 May 2006 Change of Name(s) of Applicant(s), Section 104

Newbiotics, Inc. The name of the applicant has been changed to Celmed Oncology (USA), Inc.

14 December 2006 Application Accepted

Published as AU-B-2002241911

19 April 2007 Standard Patent Sealed

14 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.